Market open
Embecta Corp./$EMBC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Embecta Corp.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
Ticker
$EMBC
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
2,100
ISIN
US29082K1051
Website
Embecta Corp. Metrics
BasicAdvanced
$677M
12.99
$0.89
1.19
$0.60
5.18%
Price and volume
Market cap
$677M
Beta
1.19
52-week high
$21.23
52-week low
$10.83
Average daily volume
552K
Dividend rate
$0.60
Financial strength
Current ratio
2.481
Quick ratio
1.589
Long term debt to equity
-210.459
Total debt to equity
-213.067
Dividend payout ratio (TTM)
65.91%
Interest coverage (TTM)
0.36%
Management effectiveness
Return on assets (TTM)
2.37%
Return on equity (TTM)
-7.01%
Valuation
Price to earnings (TTM)
12.991
Price to revenue (TTM)
0.622
Price to book
-0.92
Price to tangible book (TTM)
-0.89
Price to free cash flow (TTM)
16.918
Dividend yield (TTM)
5.18%
Forward dividend yield
5.18%
Growth
Revenue change (TTM)
-4.68%
Earnings per share change (TTM)
-26.96%
3-year revenue growth (CAGR)
-2.36%
3-year earnings per share growth (CAGR)
-48.85%
What the Analysts think about Embecta Corp.
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Embecta Corp. stock.
Embecta Corp. Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Embecta Corp. Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Embecta Corp. News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Market open
Upcoming events
May28
Embecta Corp.
Dividend·Ex-dividend
Jun13
Embecta Corp.
Dividend·Payment
$0.15Per share
FAQs
What’s the current market cap for Embecta Corp. stock?
Embecta Corp. (EMBC) has a market cap of $677M as of May 15, 2025.
What is the P/E ratio for Embecta Corp. stock?
The price to earnings (P/E) ratio for Embecta Corp. (EMBC) stock is 12.99 as of May 15, 2025.
Does Embecta Corp. stock pay dividends?
Yes, the Embecta Corp. (EMBC) stock pays dividends to shareholders. As of May 15, 2025, the dividend rate is $0.6 and the yield is 5.18%. Embecta Corp. has a payout ratio of 65.91% on a trailing twelve-month basis.
When is the next Embecta Corp. dividend payment date?
The next Embecta Corp. (EMBC) dividend payment is scheduled for June 13, 2025.
What is the beta indicator for Embecta Corp.?
Embecta Corp. (EMBC) has a beta rating of 1.19. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.